Abstract
Life-threatening myoclonus developed in a patient following inadvertent intrathecal usage of 60% diatrizoate meglumine. Rhabdomyolysis and myoglobinuria occurred. The patient was successfully treated with midazolam and vecuronium and complete recovery occurred.
MeSH terms
-
Aged
-
Contrast Media / administration & dosage
-
Contrast Media / adverse effects*
-
Diatrizoate Meglumine / administration & dosage
-
Diatrizoate Meglumine / adverse effects*
-
Humans
-
Hypnotics and Sedatives / therapeutic use
-
Injections, Spinal
-
Male
-
Midazolam / therapeutic use
-
Myoclonus / chemically induced*
-
Myoclonus / drug therapy
-
Myoglobinuria / chemically induced
-
Neuromuscular Nondepolarizing Agents / therapeutic use
-
Rhabdomyolysis / chemically induced
-
Spinal Cord Diseases / chemically induced*
-
Spinal Cord Diseases / drug therapy
-
Vecuronium Bromide / therapeutic use
Substances
-
Contrast Media
-
Hypnotics and Sedatives
-
Neuromuscular Nondepolarizing Agents
-
Diatrizoate Meglumine
-
Vecuronium Bromide
-
Midazolam